101 related articles for article (PubMed ID: 33898311)
1. Molecular Classification Based on Prognostic and Cell Cycle-Associated Genes in Patients With Colon Cancer.
Zhang Z; Ji M; Li J; Wu Q; Huang Y; He G; Xu J
Front Oncol; 2021; 11():636591. PubMed ID: 33898311
[TBL] [Abstract][Full Text] [Related]
2. Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment.
Lu W; Wang Q; Liu L; Luo W
Sci Rep; 2024 May; 14(1):10883. PubMed ID: 38740818
[TBL] [Abstract][Full Text] [Related]
3. A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM.
Cheng Q; Huang C; Cao H; Lin J; Gong X; Li J; Chen Y; Tian Z; Fang Z; Huang J
Front Genet; 2019; 10():906. PubMed ID: 31632439
[No Abstract] [Full Text] [Related]
4. A molecular sub-cluster of colon cancer cells with low VDR expression is sensitive to chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment.
Wang H; Wang X; Xu L; Zhang J; Cao H
Aging (Albany NY); 2019 Oct; 11(19):8587-8603. PubMed ID: 31596728
[TBL] [Abstract][Full Text] [Related]
5. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Cell Cycle-Related Robust Prognostic Signature in Colon Cancer.
Zhang Z; Chen J; Zhu S; Zhu D; Xu J; He G
Front Cell Dev Biol; 2020; 8():611222. PubMed ID: 33304907
[TBL] [Abstract][Full Text] [Related]
7. Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Shilpi A; Kandpal M; Ji Y; Seagle BL; Shahabi S; Davuluri RV
JCO Clin Cancer Inform; 2019 Apr; 3():1-9. PubMed ID: 31002564
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel cell cycle-related gene signature predicting survival in patients with gastric cancer.
Zhao L; Jiang L; He L; Wei Q; Bi J; Wang Y; Yu L; He M; Zhao L; Wei M
J Cell Physiol; 2019 May; 234(5):6350-6360. PubMed ID: 30238991
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
[TBL] [Abstract][Full Text] [Related]
11. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
12. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
[TBL] [Abstract][Full Text] [Related]
14. Determination of Breast Metabolic Phenotypes and Their Associations With Immunotherapy and Drug-Targeted Therapy: Analysis of Single-Cell and Bulk Sequences.
Bai M; Sun C
Front Cell Dev Biol; 2022; 10():829029. PubMed ID: 35281118
[TBL] [Abstract][Full Text] [Related]
15. Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy.
Meng J; Lu X; Zhou Y; Zhang M; Ge Q; Zhou J; Hao Z; Gao S; Yan F; Liang C
Mol Ther Oncolytics; 2021 Mar; 20():410-421. PubMed ID: 33665361
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Zhang Y; Zhang Y; Wang J; Yang J; Yang G
Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
18. Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
Vural S; Wang X; Guda C
BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):62. PubMed ID: 27587275
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer.
Wang X; Tan C; Ye M; Wang X; Weng W; Zhang M; Ni S; Wang L; Huang D; Huang Z; Xu M; Sheng W
J Cancer; 2020; 11(20):5918-5928. PubMed ID: 32922534
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Gao Z; Fu P; Yu Z; Zhen F; Gu Y
Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
